Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma

Published:2013-10 Issue:10 Volume:4 Page:e872-e872
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Zhen Yan,Liu Zhen,Yang Huiling,Yu Xiaoli,Wu Qiangyun,Hua Shengni,Long Xiaobin,Jiang Qingping,Song Ye,Cheng Chao,Wang Hao,Zhao Menyang,Fu Qiaofen,Lyu Xiaoming,Chen Yiyu,Fan Yue,Liu Yan,Li Xin,Fang Weiyi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2013376.pdf

Reference31 articles.

1. Goke A, Goke R, Knolle A, Trusheim H, Schmidt H, Wilmen A et al. DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem Biophys Res Commun 2002; 297: 78–82.

2. Ponting CP . Novel eIF4G domain homologues linking mRNA translation with nonsense-mediated mRNA decay. Trends Biochem Sci 2000; 25: 423–426.

3. Bohm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R, Klempnauer KH . The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 2003; 22: 4905–4910.

4. Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M et al. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer 2010; 9: 238.

5. Bitomsky N, Bohm M, Klempnauer KH . Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 2004; 23: 7484–7493.

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance;Cell Death Discovery;2023-11-24

2. MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers;Cancer Cell International;2023-08-16

3. Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer;European Journal of Pharmacology;2023-04

4. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma;Journal of Experimental & Clinical Cancer Research;2023-01-10

5. Prognostic value of microRNAs in patients with small cell lung cancer: a meta-analysis;World Journal of Surgical Oncology;2022-12-04